I think they would say they have looked at the latest science—at least some of the latest science—but because they have continued to focus so much on these 40- to 60-year-old studies, that raises concerns.
The more modern data shows mortality reductions in the range of 40% to perhaps even as high as 60% for women who participate in screening—emphasis on the word “participate”—and that the stage at which the cancer is found is earlier, which means it can be treated more successfully with better outcomes, less morbidity and at lower cost. I don't see that in anything the task force has put in its literature. I've read its reports. There's nothing that clarifies that it has taken the more modern data seriously.
As mentioned earlier today, there's nothing on breast density. There's nothing on women who are racialized, whose breast cancers tend to occur earlier and be more aggressive in some cases and whose outcomes, we know, are worse. They do much worse. There's an inequity there.